DERIVAŢI IZOSTERI AI SUBSTRATULUI ASPARTAT PROTEAZEI, SĂRURILE LOR, COMPOZIŢII FARMACEUTICE ŞI UTILIZARE

Price not visible for this package

Interest:

Assignment

Publication info:

No.: RO119413

Date: 29.10.2004

Inventor(s):

BOLD GUIDO [CH]

CAPRARO HANS GEORG [CH]

FASSLER ALEXANDER [CH]

LANG MARC [FR]

BHAGWAT SHRIPAD SUBRAY [US]

KHANNA SATISH CHANDRA [CH]

LAZDINS JANIS KARLIS [CH]

MESTAN JURGEN [DE]

Applicant(s):
CIBA GEIGY AG [CH]
Classification:
International patent classification (IPC):
A61K31/075; A61K31/16; A61K31/165; A61K31/275; A61K31/325; A61K31/35; A61K31/351; A61K31/352; A61K31/395; A61K31/425; A61K31/426; A61K31/44; A61K31/4406; A61K31/4418; A61K31/4427; A61K31/445; A61K31/47; A61K31/495; A61K31/535; A61K31/5375; A61K31/695; A61K38/05; A61P31/12; A61P31/18; C07C237/22; C07C255/60; C07C271/22; C07C311/19; C07C311/42; C07C317/50; C07D207/12; C07D207/16; C07D207/26; C07D207/28; C07D209/18; C07D209/42; C07D211/40; C07D211/46; C07D211/48; C07D211/60; C07D211/62; C07D213/30; C07D213/65; C07D213/81; C07D213/82; C07D277/06; C07D277/20; C07D277/40; C07D277/56; C07D295/12; C07D295/155; C07D295/215; C07D307/20; C07D307/33; C07D309/04; C07D309/12; C07D311/24; C07D317/60; C07D401/04; C07K5/00; C07C233/16

Cooperative patent classification (CPC):
A61K31/47 (EP, US); A61K31/495 (EP, US); A61P31/12 (EP); A61P31/18 (EP); C07C237/12 (KR); C07C255/60 (EP, US); C07C271/22 (EP, US); C07C311/19 (EP, US); C07C311/42 (EP, US); C07C317/50 (EP, US); C07D207/26 (EP, US); C07D207/28 (EP, US); C07D209/42 (EP, US); C07D211/46 (EP, US); C07D211/62 (EP, US); C07D213/30 (EP, US); C07D213/82 (EP, US); C07D277/06 (EP, US); C07D277/40 (EP, US); C07D295/155 (EP, US); C07D307/20 (EP, US); C07D309/04 (EP, US); C07D309/12 (EP, US); C07D311/24 (EP, US); C07D317/60 (EP, US); C07C2601/14 (EP, US); C07C2602/10 (EP, US); A61K31/47; A61K2300/00; A61K31/495
Application info:
No.: RO19950001805
Date: 18.10.1995
Priority number(s):
CH19940003140 19.10.1994 ; CH19950002382 21.08.1995
Related patents:
ATE220661; AU3427995; AU707283; BG100067; BG63042; BR9504466; CA2160763; CN1132756; CZ271395; CZ290123; DE69527405; DK0708085; EP0708085; ES2180600; FI954913; HUT74744; JP3192070; JPH08208580; KR960014094; MX9504415; NO314457; NO954142; NZ280256; PL184292; PL311027; PT708085; RU2164229; SK128595; SK282339; TR199501284; US5663200; US5807891; US5935976
Description:

Invenţia se referă la derivaţi izosteri ai substratului aspartat proteazei cu formula I:şi la sărurile acestora, la compoziţii farmaceutice care cuprind aceşti derivaţi sau sărurile lor, şi la utilizarea acestora. Derivaţii izosteri ai aspartat proteazei sunt singuri sau în combinaţie cu alţi compuşi eficienţi împotriva retroviruşilor. ŕ

cover